Bharat Biotech International Ltd, a Hyderabad-based manufacturer of vaccines and biotherapeutics, has been selected by the Orissa government to set up the state’s first public-private-partnership biotech pharma IT project.
The park, to be located at Mouza-Andharua near Bhubaneswar, is estimated to cost about Rs 100 crore and is slated to be completed in eight years.
The Orissa government has allocated 54.86 acres to Bharat Biotech towards the development of the integrated industrial park to attract and promote pharmaceutical, biotechnology and IT industries in the state.
Bharat Biotech will form an to develop the proposed park. The SPV will execute the lease-cum-development agreement of Bharat Biotech with the Orissa Industrial Infrastructure Development Corporation (Idco).
The state government and Idco have agreed to provide all external infrastructure facilities such as road connectivity, water and power supply with a 33 KVA sub-station to facilitate rapid development of internal infrastructure, the company stated in a release on Wednesday.
Within the proposed park, another 10 acre will be developed to house a biotechnology incubation centre for use by researchers, entrepreneurs and students.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
